India · Delayed Price · Currency is INR Biopol Chemicals Statistics
Total Valuation
NSE:BIOPOL has a market cap or net worth of INR 454.91 million. The enterprise value is 534.37 million.
| Market Cap | 454.91M |
| Enterprise Value | 534.37M |
Important Dates
The next confirmed earnings date is Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:BIOPOL has 10.81 million shares outstanding.
| Current Share Class | 10.81M |
| Shares Outstanding | 10.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 67.66% |
| Owned by Institutions (%) | n/a |
| Float | 2.89M |
Valuation Ratios
The trailing PE ratio is 3.89.
| PE Ratio | 3.89 |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.41 |
| EV / Sales | 0.71 |
| EV / EBITDA | 4.25 |
| EV / EBIT | 4.28 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.73 |
| Quick Ratio | 2.05 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | n/a |
| Interest Coverage | 10.87 |
Financial Efficiency
Return on equity (ROE) is 28.26% and return on invested capital (ROIC) is 25.62%.
| Return on Equity (ROE) | 28.26% |
| Return on Assets (ROA) | 16.54% |
| Return on Invested Capital (ROIC) | 25.62% |
| Return on Capital Employed (ROCE) | 24.39% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 28.98M |
| Profits Per Employee | 3.21M |
| Employee Count | 28 |
| Asset Turnover | 1.60 |
| Inventory Turnover | 4.02 |
Taxes
In the past 12 months, NSE:BIOPOL has paid 30.84 million in taxes.
| Income Tax | 30.84M |
| Effective Tax Rate | 25.58% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 61.35 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 32.55 |
| Average Volume (20 Days) | 22,380 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:BIOPOL had revenue of INR 811.43 million and earned 89.74 million in profits. Earnings per share was 10.83.
| Revenue | 811.43M |
| Gross Profit | 180.17M |
| Operating Income | 134.27M |
| Pretax Income | 120.58M |
| Net Income | 89.74M |
| EBITDA | 135.25M |
| EBIT | 134.27M |
| Earnings Per Share (EPS) | 10.83 |
Balance Sheet
The company has 5.18 million in cash and 84.65 million in debt, with a net cash position of -79.47 million or -7.35 per share.
| Cash & Cash Equivalents | 5.18M |
| Total Debt | 84.65M |
| Net Cash | -79.47M |
| Net Cash Per Share | -7.35 |
| Equity (Book Value) | 499.21M |
| Book Value Per Share | 46.20 |
| Working Capital | 402.87M |
Cash Flow
In the last 12 months, operating cash flow was -127.66 million and capital expenditures -142.00 million, giving a free cash flow of -269.66 million.
| Operating Cash Flow | -127.66M |
| Capital Expenditures | -142.00M |
| Depreciation & Amortization | 983,000 |
| Net Borrowing | 7.80M |
| Free Cash Flow | -269.66M |
| FCF Per Share | -24.96 |
Margins
Gross margin is 22.20%, with operating and profit margins of 16.55% and 11.06%.
| Gross Margin | 22.20% |
| Operating Margin | 16.55% |
| Pretax Margin | 14.86% |
| Profit Margin | 11.06% |
| EBITDA Margin | 16.67% |
| EBIT Margin | 16.55% |
| FCF Margin | n/a |
Dividends & Yields
NSE:BIOPOL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 25.72% |
| FCF Yield | -54.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |